Medifast Inc. (MED)

NYSE: MED · Real-Time Price · USD

12.99

-0.15 (-1.14%)

At close: May 01, 2025, 3:59 PM

12.98

-0.08%

After-hours: May 01, 2025, 05:46 PM EDT

-1.14% (1D)

Bid	12.71
Market Cap	142.08M
Revenue (ttm)	543.45M
Net Income (ttm)	-7M
EPS (ttm)	0.19
PE Ratio (ttm)	68.37
Forward PE	-26.86
Analyst	Hold

Ask	13.25
Volume	291,206
Avg. Volume (20D)	231,693
Open	13.00
Previous Close	13.14
Day's Range	12.62 - 13.17
52-Week Range	11.57 - 28.44
Beta	1.08

About MED

Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life...

[Read more]

Industry Personal Products & Services

Sector Consumer Cyclical

IPO Date Dec 30, 1993

Employees 504

Stock Exchange NYSE

Ticker Symbol MED

Website https://medifastinc.com

Full Company Profile

Analyst Forecast

According to 1 analyst ratings, the average rating for MED stock is "Hold." The 12-month stock price forecast is $16.5, which is an increase of 27.02% from the latest price.

Stock Forecasts

Earnings Surprise

Medifast has released their quartely earnings on Apr 28, 2025:

Revenue of $115.73M misses estimates by $672K, with -33.77% YoY decline.

EPS of -0.07 exceeds estimates by 0.18, with -110.61% YoY decline.

Why Price Moved

11 months ago

-8.14%

MEDIFAST shares are trading lower after DA Davidso... Unlock content with Pro Subscription

News

3 days ago · zacks.com

Medifast Q1 Loss Wider Than Expected, Sales Down 33.8% Y/Y

MED's first-quarter results show challenges from fewer active OPTAVIA Coaches. Nonetheless, the company is focusing on revitalizing its coach base for growth.

4 days ago · seekingalpha.com

Medifast, Inc. (MED) Q1 2025 Earnings Call Transcript

Medifast, Inc. (NYSE:MED ) Q1 2025 Earnings Conference Call April 28, 2025 4:30 PM ET Company Participants Steven Zenker - Vice President, Investor Relations Dan Chard - Chairman and CEO Jim Maloney -...

4 days ago · businesswire.com

Medifast Announces First Quarter 2025 Financial Results

BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the first quarter ...

1 week ago · zacks.com

Medifast to Report Q1 Earnings: What Investors Should Expect

MED's first-quarter results may show challenges in customer acquisition amid market headwinds and shifting consumer trends.

2 weeks ago · zacks.com

Medifast Trades Near 52-Week Low: What's the Best Move Now?

MED faces steep revenue declines and coach losses but aims to rebound through innovation, marketing and new GLP-1-focused initiatives.

1 month ago · seekingalpha.com

Medifast: GLP-1 Caused A Vicious MLM Flywheel Effect

Medifast, Inc.'s business is deteriorating as GLP-1 medication has lowered demand, causing a vicious flywheel effect as coaches are exiting the platform. The company is trying to reposition itself as ...

2 months ago · zacks.com

MED Q4 Earnings Beat, Revenues Dip Y/Y on Lower Customer Acquisition

Medifast's Q2 results show challenges related to weak customer acquisition. However, it is prioritizing efforts to enhance coach productivity in the near term.

2 months ago · seekingalpha.com

Medifast, Inc. (MED) Q4 2024 Earnings Call Transcript

Medifast, Inc. (NYSE:MED ) Q4 2024 Earnings Conference Call February 18, 2025 4:30 PM ET Company Participants Steven Zenker - Vice President, Investor Relations Dan Chard - Chairman and Chief Executiv...

2 months ago · zacks.com

Medifast (MED) Q4 Earnings and Revenues Beat Estimates

Medifast (MED) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of a loss of $0.27 per share. This compares to earnings of $1.09 per share a year ago.

2 months ago · businesswire.com

Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2024

BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the fourt...